Inmune Bio, Inc. Contracts & Agreements
78 Contracts & Agreements
- Business Finance (26 contracts)
- Business Operations (10)
- Human Resources (12)
- Intellectual Property (9)
- Real Estate (1)
- Uncategorized (20)
- At-the-Market Sales Agreement, dated August 9, 2024, by and among INmune Bio Inc., RBC Capital Markets, LLC and BTIG, LLC (Filed With SEC on August 9, 2024)
- Incentive Stock Option Agreement between INmune Bio Inc. and Dr. Tesi, dated June 10, 2024 (Filed With SEC on June 13, 2024)
- Form of Nonqualified Option Agreement of INmune Bio Inc (Filed With SEC on May 16, 2024)
- Form of Incentive Stock Option Agreement of INmune Bio Inc (Filed With SEC on May 16, 2024)
- Form of Warrant (Filed With SEC on April 26, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on April 26, 2024)
- Form of Placement Agency Agreement (Filed With SEC on April 26, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on April 22, 2024)
- Form of Placement Agency Agreement (Filed With SEC on April 22, 2024)
- Form of Warrant (Filed With SEC on April 22, 2024)
- Amendment No. 3 to Rights Agreement, dated as of December 14, 2023, between the Company and VStock Transfer LLC, as Rights Agent (Filed With SEC on December 18, 2023)
- Amendment No. 1 to At-the-Market Sales Agreement, dated August 16, 2023, between INmune Bio Inc., and BTIG, LLC (Filed With SEC on August 16, 2023)
- AMENDED AND RESTATED INMUNE BIO, INC. 2021 STOCK INCENTIVE PLAN (Filed With SEC on June 1, 2023)
- First Amendment to Exclusive License Agreement between INmune Bio Inc. and Immune Ventures LLC dated April 17, 2023 (Filed With SEC on April 20, 2023)
- Second Amendment to Exclusive License Agreement by and between the University of Pittsburgh of the Commonwealth system of Higher Education and Immune Ventures, LLC dated April 17,... (Filed With SEC on April 20, 2023)
- Amendment No. 2 to Rights Agreement, dated as of December 9, 2022, between the Company and VStock Transfer LLC, as Rights Agent (Filed With SEC on December 12, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on March 24, 2022)
- Form of Option Agreement between the Company and Non-Employee Directors and consultants (Filed With SEC on March 24, 2022)
- Form of Option Agreement for Employees of the Company (Filed With SEC on March 24, 2022)
- Description of Securities of INmune Bio, Inc (Filed With SEC on March 3, 2022)
- Amendment No. 1 to Rights Agreement, dated as of December 20, 2021, between INmune Bio Inc. and Vstock Transfer, LLC (Filed With SEC on December 21, 2021)
- Lease Agreement dated September 13, 2021 (Filed With SEC on September 15, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on July 15, 2021)
- Form of Placement Agency Agreement (Filed With SEC on July 15, 2021)
- Form of Option Agreement between the Company and Non-Employee Directors (Filed With SEC on June 24, 2021)
- Form of Option Agreement for Employees of the Company (Filed With SEC on June 24, 2021)
- Option Cancellation Agreement between INmune Bio Inc. and Xencor, Inc (Filed With SEC on June 15, 2021)
- First Amendment to License Agreement (Filed With SEC on June 15, 2021)
- Loan and Security Agreement (Filed With SEC on June 15, 2021)
- Warrant to Purchase Common Stock issued to SVB Innovation Credit Fund VIII, L.P (Filed With SEC on June 15, 2021)
- Warrant to Purchase Common Stock issued to Silicon Valley Bank (Filed With SEC on June 15, 2021)
- INmune Bio, Inc. 2021 Stock Incentive Plan (Filed With SEC on June 3, 2021)
- Form of agreement between INmune Bio Inc. and National Securities Corporation, dated March 29, 2021 (Filed With SEC on March 29, 2021)
- At-The-Market Sales Agreement, dated March 10, 2021, between the Company and BTIG (Filed With SEC on March 11, 2021)
- Employment Agreement effective as of January 1, 2021 between INmune Bio Inc. and Raymond J. Tesi (attached hereto) (Filed With SEC on March 4, 2021)
- Employment Agreement effective as of January 1, 2021 between INmune Bio Inc. and David Moss (attached hereto) (Filed With SEC on March 4, 2021)
- Rights Agreement, dated as of December 30, 2020, by and between INmune Bio Inc. and VStock Transfer, LLC (Filed With SEC on January 4, 2021)
- Rights Agreement, dated as of December 30, 2020, by and between INmune Bio Inc. and VStock Transfer, LLC (Filed With SEC on December 30, 2020)
- Amendment to Exclusive License Agreement (Filed With SEC on November 5, 2020)
- Amendment No. 1 to At-The-Market Sales Agreement, dated April 16, 2020, between the Company and BTIG (Filed With SEC on August 19, 2020)
- Underwriting Agreement, dated July 16, 2020, by and between INmune Bio, Inc. and BTIG, Inc., as representative of the underwriters named therein (Filed With SEC on July 16, 2020)
- At-The-Market Sales Agreement, dated April 16, 2020, between the Company and BTIG (Filed With SEC on April 17, 2020)
- INmune Bio, Inc. 2019 Stock Incentive Plan (attached hereto) (Filed With SEC on March 11, 2020)
- Award Agreement dated as of February 4, 2020 (Filed With SEC on February 10, 2020)
- Common Stock Repurchase Agreement (Filed With SEC on January 27, 2020)
- Amendment No. 2 to Securities Purchase Agreement between INmune Bio, Inc. and Raymond J. Tesi (Filed With SEC on May 24, 2019)
- Amendment to Securities Purchase Agreement between INmune Bio, Inc. and Raymond J. Tesi (Filed With SEC on May 17, 2019)
- Amendment to Securities Purchase Agreement between INmune Bio, Inc. and David J. Moss (Filed With SEC on May 17, 2019)
- Purchase Agreement between INmune Bio Inc. and Lincoln Park Capital Fund, LLC, dated May 15, 2019 (Filed With SEC on May 16, 2019)
- Registration Rights Agreement between INmune Bio Inc. and Lincoln Park Capital Fund, LLC, dated May 15, 2019 (Filed With SEC on May 16, 2019)
- Award Letter dated as of February 22, 2019 from the Alzheimers Association to INmune Bio, Inc (Filed With SEC on February 28, 2019)
- Form of Placement Agent Agreement (Filed With SEC on November 20, 2018)
- Form of Placement Agent Common Stock Warrant (Filed With SEC on November 20, 2018)
- Form of Subscription Agreement (Filed With SEC on November 20, 2018)
- Form of Lock-up Agreement (Filed With SEC on October 29, 2018)
- Form of Placement Agent Agreement (Filed With SEC on September 26, 2018)
- Form of Registrants common stock certificate (Filed With SEC on September 26, 2018)
- Form of Placement Agent Common Stock Warrant (Filed With SEC on September 26, 2018)
- Form of Waiver of Registration Rights (Filed With SEC on September 26, 2018)
- SUBSCRIPTION AGREEMENT Common Stock of Inmune Bio Inc. (Filed With SEC on September 26, 2018)
- Form of Subscription Agreement (Filed With SEC on August 30, 2018)
- License Agreement between INmune Bio, Inc. and Immune Ventures LLC (Filed With SEC on August 30, 2018)
- Assignment and Assumption Agreement with Immune Ventures LLC (Filed With SEC on August 30, 2018)
- Exclusive License Agreement by the University of Pittsburgh of the Common Wealth system of Higher Education and Immune Ventures LLC (Filed With SEC on August 30, 2018)
- First Amendment to Exclusive License Agreement by and between the University of Pittsburgh of the Commonwealth system of Higher Education and Immune Ventures, LLC (Filed With SEC on August 30, 2018)
- Joint Development Agreement between INmune Bio, Inc. and Novamune (Filed With SEC on August 30, 2018)
- Material Transfer and License Agreement between Anthony Nolan Cord Blood Bank and Immune Bio International LTD (Filed With SEC on August 30, 2018)
- Employment Agreement between INmune Bio Inc. and Raymond Tesi (Filed With SEC on August 30, 2018)
- Employment Agreement between INmune Bio Inc. and David Moss (Filed With SEC on August 30, 2018)
- Consulting Agreement between INmune Bio Inc. and Mark Lowdell (Filed With SEC on August 30, 2018)
- INmune Bio, Inc. 2017 Stock Incentive Plan (Filed With SEC on August 30, 2018)
- Form of Incentive Option Agreement with employees (Filed With SEC on August 30, 2018)
- Form of Incentive Option Agreement with non-employee directors (Filed With SEC on August 30, 2018)
- Consultant Agreement between INmune Bio Inc. and Pacific Seaboard Investments Ltd (Filed With SEC on August 30, 2018)
- License Agreement between INMune Bio Inc. and Xencor, Inc (Filed With SEC on August 30, 2018)
- Voting Agreement between INmune Bio Inc. and Xencor, Inc (Filed With SEC on August 30, 2018)
- Amendment to the Consultancy Agreement between INMune Bio Inc. and Mark Lowdell (Filed With SEC on August 30, 2018)
- First Amendment to Stock Issuance Agreement (Filed With SEC on August 30, 2018)
